European Forum on Antiphospholipid Antibodies

Publications

Several publications were published thanks to European collaborations in the field of APS since 20 years!

1: Alijotas-Reig J, Esteve-Valverde E, Ferrer-Oliveras R, Sáez-Comet L, Lefkou E,
Mekinian A, Belizna C, Ruffatti A, Tincani A, Marozio L, Espinosa G, Cervera R,
Ríos-Garcés R, De Carolis S, Latino O, LLurba E, Chighizola CB, Gerosa M, Pengo
V, Lundelin K, Rovere-Querini P, Canti V, Mayer-Pickel K, Reshetnyak T, Hoxha A,
Tabacco S, Stojanovich L, Gogou V, Varoudis A, Arnau A, Ruiz-Hidalgo D, Trapé J,
Sos L, Stoppani C, Martí-Cañamares A, Farran-Codina I; EUROAPS Study Group. The
European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of
1000 consecutive cases. Autoimmun Rev. 2019 Feb 15. pii: S1568-9972(19)30038-2.
doi: 10.1016/j.autrev.2018.12.006. [Epub ahead of print] Review. PubMed PMID:
30772493.

2: Chayouâ W, Yin D, de Groot PG, Zuily S, Wahl D, de Laat B, Kelchtermans H.
Brief Report on the 11th Meeting of the European Forum on Antiphospholipid
Antibodies. Curr Rheumatol Rep. 2019 Feb 11;21(2):6. doi:
10.1007/s11926-019-0805-1. Review. PubMed PMID: 30741359; PubMed Central PMCID:
PMC6373334.

3: Eschwège V, Yelnik CM, Zuily S, Wahl D. Brief Report on the 10th Meeting of
the European Forum on Antiphospholipid Antibodies. Curr Rheumatol Rep. 2018 Aug
21;20(10):63. doi: 10.1007/s11926-018-0767-8. Review. PubMed PMID: 30128935.

4: Alijotas-Reig J, Esteve-Valverde E, Ferrer-Oliveras R, LLurba E, Ruffatti A,
Tincani A, Lefkou E, Bertero MT, Espinosa G, de Carolis S, Rovere-Querini P,
Lundelin K, Picardo E, Mekinian A; EUROAPS Study Group. Comparative study between
obstetric antiphospholipid syndrome and obstetric morbidity related with
antiphospholipid antibodies. Med Clin (Barc). 2018 Sep 21;151(6):215-222. doi:
10.1016/j.medcli.2017.11.017. Epub 2017 Dec 20. English, Spanish. PubMed PMID:
29274674.

5: Mekinian A, Alijotas-Reig J, Carrat F, Costedoat-Chalumeau N, Ruffatti A,
Lazzaroni MG, Tabacco S, Maina A, Masseau A, Morel N, Esteve-Valverde EE,
Ferrer-Oliveras R, Andreoli L, De Carolis S, Josselin-Mahr L, Abisror N,
Nicaise-Roland P, Tincani A, Fain O; on the behalf of the SNFMI and the European
Forum on Antiphospholipid Antibodies. Refractory obstetrical antiphospholipid
syndrome: Features, treatment and outcome in a European multicenter retrospective
study. Autoimmun Rev. 2017 Jul;16(7):730-734. doi: 10.1016/j.autrev.2017.05.006.
Epub 2017 May 4. Review. PubMed PMID: 28478081.

6: Rodríguez-Pintó I, Moitinho M, Santacreu I, Shoenfeld Y, Erkan D, Espinosa G,
Cervera R; CAPS Registry Project Group (European Forum on Antiphospholipid
Antibodies). Catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis
of 500 patients from the International CAPS Registry. Autoimmun Rev. 2016
Dec;15(12):1120-1124. doi: 10.1016/j.autrev.2016.09.010. Epub 2016 Sep 15.
Review. PubMed PMID: 27639837.

7: Kazzaz NM, McCune WJ, Knight JS. Treatment of catastrophic antiphospholipid
syndrome. Curr Opin Rheumatol. 2016 May;28(3):218-27. doi:
10.1097/BOR.0000000000000269. Review. PubMed PMID: 26927441; PubMed Central
PMCID: PMC4958413.

8: Mekinian A, Lazzaroni MG, Kuzenko A, Alijotas-Reig J, Ruffatti A, Levy P,
Canti V, Bremme K, Bezanahary H, Bertero T, Dhote R, Maurier F, Andreoli L,
Benbara A, Tigazin A, Carbillon L, Nicaise-Roland P, Tincani A, Fain O; SNFMI and
the European Forum on Antiphospholipid Antibodies. The efficacy of
hydroxychloroquine for obstetrical outcome in anti-phospholipid syndrome: Data
from a European multicenter retrospective study. Autoimmun Rev. 2015
Jun;14(6):498-502. doi: 10.1016/j.autrev.2015.01.012. Epub 2015 Jan 21. Review.
PubMed PMID: 25617818.

9: Alijotas-Reig J, Ferrer-Oliveras R, Ruffatti A, Tincani A, Lefkou E, Bertero
MT, Coloma-Bazan E, de Carolis S, Espinosa G, Rovere-Querini P, Kuzenko A,
Valverde EE, Robles A, Cervera R, Canti V, Fredi M, Gil-Aguado A, Lundelin K,
Llurba E, Melnychuk T, Nalli C, Picardo E, Silvestro E, del Ross T, Farran-Codina
I; (EUROAPS Study Group Collaborators). The European Registry on Obstetric
Antiphospholipid Syndrome (EUROAPS): A survey of 247 consecutive cases. Autoimmun
Rev. 2015 May;14(5):387-95. doi: 10.1016/j.autrev.2014.12.010. Epub 2014 Dec 31.
Review. PubMed PMID: 25555817.

10: Swadzba J, Sydor WJ, Kolodziejczyk J, Musial J. Summary of the 9th meeting of
the European Forum on Antiphospholipid Antibodies. Lupus. 2014 Apr;23(4):395-9.
doi: 10.1177/0961203314520841. Epub 2014 Jan 28. PubMed PMID: 24474705.

11: Cervera R, Serrano R, Pons-Estel GJ, Ceberio-Hualde L, Shoenfeld Y, de Ramón
E, Buonaiuto V, Jacobsen S, Zeher MM, Tarr T, Tincani A, Taglietti M,
Theodossiades G, Nomikou E, Galeazzi M, Bellisai F, Meroni PL, Derksen RH, de
Groot PG, Baleva M, Mosca M, Bombardieri S, Houssiau F, Gris JC, Quéré I,
Hachulla E, Vasconcelos C, Fernández-Nebro A, Haro M, Amoura Z, Miyara M,
Tektonidou M, Espinosa G, Bertolaccini ML, Khamashta MA; Euro-Phospholipid
Project Group (European Forum on Antiphospholipid Antibodies). Morbidity and
mortality in the antiphospholipid syndrome during a 10-year period: a multicentre
prospective study of 1000 patients. Ann Rheum Dis. 2015 Jun;74(6):1011-8. doi:
10.1136/annrheumdis-2013-204838. Epub 2014 Jan 24. PubMed PMID: 24464962.

12: Berman H, Rodríguez-Pintó I, Cervera R, Gregory S, de Meis E, Rodrigues CE,
Aikawa NE, de Carvalho JF, Springer J, Niedzwiecki M, Espinosa G; Catastrophic
Registry Project Group (European Forum on Antiphospholipid Antibodies). Pediatric
catastrophic antiphospholipid syndrome: descriptive analysis of 45 patients from
the "CAPS Registry". Autoimmun Rev. 2014 Feb;13(2):157-62. doi:
10.1016/j.autrev.2013.10.004. Epub 2013 Oct 19. PubMed PMID: 24145009.

13: Berman H, Rodríguez-Pintó I, Cervera R, Morel N, Costedoat-Chalumeau N, Erkan
D, Shoenfeld Y, Espinosa G; Catastrophic Antiphospholipid Syndrome (CAPS)
Registry Project Group (European Forum on Antiphospholipid Antibodies). Rituximab
use in the catastrophic antiphospholipid syndrome: descriptive analysis of the
CAPS registry patients receiving rituximab. Autoimmun Rev. 2013
Sep;12(11):1085-90. doi: 10.1016/j.autrev.2013.05.004. Epub 2013 Jun 15. PubMed
PMID: 23777822.

14: Espinosa G, Rodríguez-Pintó I, Gomez-Puerta JA, Pons-Estel G, Cervera R;
Catastrophic Antiphospholipid Syndrome (CAPS) Registry Project Group (European
Forum on Antiphospholipid Antibodies). Relapsing catastrophic antiphospholipid
syndrome potential role of microangiopathic hemolytic anemia in disease relapses.
Semin Arthritis Rheum. 2013 Feb;42(4):417-23. doi:
10.1016/j.semarthrit.2012.05.005. Epub 2012 Jul 10. PubMed PMID: 22784445.

15: Alijotas-Reig J, Ferrer-Oliveras R; EUROAPS Study Group. The European
Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): a preliminary first
year report. Lupus. 2012 Jun;21(7):766-8. doi: 10.1177/0961203312440058. PubMed
PMID: 22635227.

16: Cervera R. CAPS Registry. Lupus. 2012 Jun;21(7):755-7. doi:
10.1177/0961203312436866. PubMed PMID: 22635223.

17: Cervera R. European Forum On Antiphospholipid Antibodies: brief history
report and governance document. Lupus. 2012 Jun;21(7):699-703. doi:
10.1177/0961203312436865. PubMed PMID: 22635206.

18: Cervera R, Espinosa G. Update on the catastrophic antiphospholipid syndrome
and the "CAPS Registry". Semin Thromb Hemost. 2012 Jun;38(4):333-8. doi:
10.1055/s-0032-1304718. Epub 2012 Mar 5. PubMed PMID: 22618528.

19: Cucnik S, Kveder T, Ulcova-Gallova Z, Swadzba J, Musial J, Valesini G, Avcin
T, Rozman B, Bozic B. The avidity of anti-beta2-glycoprotein I antibodies in
patients with or without antiphospholipid syndrome: a collaborative study in the
frame of the European forum on antiphospholipid antibodies. Lupus. 2011
Oct;20(11):1166-71. doi: 10.1177/0961203311406308. Epub 2011 Jun 28. Erratum in:
Lupus. 2011 Dec;20(14):1569. Ulcova, G Z [corrected to Ulcova-Gallova, Z]. PubMed
PMID: 21712304.

20: Cervera R; CAPS Registry Project Group. Catastrophic antiphospholipid
syndrome (CAPS): update from the 'CAPS Registry'. Lupus. 2010 Apr;19(4):412-8.
doi: 10.1177/0961203309361353. PubMed PMID: 20353979.

21: Vasconcelos C, Cervera R. Networking in Europe for special centres of
excellence for autoimmune diseases. Lupus. 2009 Sep;18(10):930-2. doi:
10.1177/0961203309106834. PubMed PMID: 19671795.

22: Meroni PL, Tincani A, Alarcón-Riquelme ME, Shoenfeld Y, Borghi MO. European
Forum on Antiphospholipid Antibodies: research in progress. Lupus. 2009
Sep;18(10):924-9. doi: 10.1177/0961203309106916. Review. PubMed PMID: 19671794.

23: Tincani A, Filippini M, Scarsi M, Galli M, Meroni PL. European attempts for
the standardisation of the antiphospholipid antibodies. Lupus. 2009
Sep;18(10):913-9. doi: 10.1177/0961203309106919. PubMed PMID: 19671792.

24: Bucciarelli S, Espinosa G, Cervera R. The CAPS Registry: morbidity and
mortality of the catastrophic antiphospholipid syndrome. Lupus. 2009
Sep;18(10):905-12. doi: 10.1177/0961203309106833. PubMed PMID: 19671791.

25: Avcin T, Cimaz R, Rozman B; Ped-APS Registry Collaborative Group. The Ped-APS
Registry: the antiphospholipid syndrome in childhood. Lupus. 2009
Sep;18(10):894-9. doi: 10.1177/0961203309106917. PubMed PMID: 19671789.

26: Cervera R, Tincani A. European Working Party on systemic lupus erythematosus
and European Forum on Antiphospholipid Antibodies: two networks promoting
European research on autoimmunity. Lupus. 2009 Sep;18(10):863-8. doi:
10.1177/0961203309106812. PubMed PMID: 19671783.

27: Cervera R, Bucciarelli S, Plasín MA, Gómez-Puerta JA, Plaza J, Pons-Estel G,
Shoenfeld Y, Ingelmo M, Espinos G; Catastrophic Antiphospholipid Syndrome (CAPS)
Registry Project Group (European Forum On Antiphospholipid Antibodies).
Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series
of 280 patients from the "CAPS Registry". J Autoimmun. 2009
May-Jun;32(3-4):240-5. doi: 10.1016/j.jaut.2009.02.008. Epub 2009 Mar 26. PubMed
PMID: 19324520.

28: Rotar Z, Rozman B, de Groot PG, Sanmarco M, Shoenfeld Y, Meroni PL, Cervera
R, Pengo V, Cimaz R, Avcin T, Carp HJ, Tincani A. Sixth meeting of the European
Forum on antiphospholipid antibodies. How to improve the understanding of the
antiphospholipid syndrome? Lupus. 2009 Jan;18(1):53-60. doi:
10.1177/0961203308097569. PubMed PMID: 19074169.

29: Stojanovich L, Marisavljevic D, Rovensky J, Djokovich A, Kozáková D, Milinic
N. Clinical and laboratory features of the catastrophic antiphospholipid
syndrome. Clin Rev Allergy Immunol. 2009 Jun;36(2-3):74-9. doi:
10.1007/s12016-008-8108-8. Review. PubMed PMID: 19052923.

30: Stojanovich L. The catastrophic antiphospholipid syndrome in Serbia:
diagnostic and management problems. Clin Rev Allergy Immunol. 2009
Jun;36(2-3):98-103. doi: 10.1007/s12016-008-8102-1. PubMed PMID: 19048415.

31: Avcin T, Cimaz R, Silverman ED, Cervera R, Gattorno M, Garay S, Berkun Y,
Sztajnbok FR, Silva CA, Campos LM, Saad-Magalhaes C, Rigante D, Ravelli A,
Martini A, Rozman B, Meroni PL. Pediatric antiphospholipid syndrome: clinical and
immunologic features of 121 patients in an international registry. Pediatrics.
2008 Nov;122(5):e1100-7. doi: 10.1542/peds.2008-1209. Epub 2008 Oct 27. PubMed
PMID: 18955411.

32: Cervera R, Khamashta MA, Shoenfeld Y, Camps MT, Jacobsen S, Kiss E, Zeher MM,
Tincani A, Kontopoulou-Griva I, Galeazzi M, Bellisai F, Meroni PL, Derksen RH, de
Groot PG, Gromnica-Ihle E, Baleva M, Mosca M, Bombardieri S, Houssiau F, Gris JC,
Quéré I, Hachulla E, Vasconcelos C, Roch B, Fernández-Nebro A, Piette JC,
Espinosa G, Bucciarelli S, Pisoni CN, Bertolaccini ML, Boffa MC, Hughes GR;
Euro-Phospholipid Project Group (European Forum on Antiphospholipid Antibodies).
Morbidity and mortality in the antiphospholipid syndrome during a 5-year period:
a multicentre prospective study of 1000 patients. Ann Rheum Dis. 2009
Sep;68(9):1428-32. doi: 10.1136/ard.2008.093179. Epub 2008 Sep 18. PubMed PMID:
18801761.

33: Cervera R. Lessons from the "Euro-Phospholipid" project. Autoimmun Rev. 2008
Jan;7(3):174-8. doi: 10.1016/j.autrev.2007.11.011. Epub 2007 Dec 3. Review.
PubMed PMID: 18190874.

34: Ravelli A, Martini A. Antiphospholipid syndrome in pediatrics. Rheum Dis Clin
North Am. 2007 Aug;33(3):499-523. PubMed PMID: 17936175.

35: Cervera R, Bucciarelli S, Espinosa G, Gómez-Puerta JA, Ramos-Casals M,
Shoenfeld Y, Piette JC, Asherson RA. Catastrophic antiphospholipid syndrome:
lessons from the "CAPS Registry"--a tribute to the late Josep Font. Ann N Y Acad
Sci. 2007 Jun;1108:448-56. Review. PubMed PMID: 17894009.

36: Sanmarco M, Gayet S, Alessi MC, Audrain M, de Maistre E, Gris JC, de Groot
PG, Hachulla E, Harlé JR, Sié P, Boffa MC. Antiphosphatidylethanolamine
antibodies are associated with an increased odds ratio for thrombosis. A
multicenter study with the participation of the European Forum on
antiphospholipid antibodies. Thromb Haemost. 2007 Jun;97(6):949-54. PubMed PMID:
17549297.

37: Cervera R, Espinosa G, Bucciarelli S, Gómez-Puerta JA, Font J. Lessons from
the catastrophic antiphospholipid syndrome (CAPS) registry. Autoimmun Rev. 2006
Dec;6(2):81-4. Epub 2006 Jul 21. Review. PubMed PMID: 17138248.

38: Cervera R, Font J, Tincani A, Boffa MC. V meeting of the European forum on
antiphospholipid antibodies. Autoimmun Rev. 2006 Aug;5(7):499-507. Epub 2006 Feb
3. PubMed PMID: 16920577.

39: Bucciarelli S, Espinosa G, Cervera R, Erkan D, Gómez-Puerta JA, Ramos-Casals
M, Font J, Asherson RA; European Forum on Antiphospholipid Antibodies. Mortality
in the catastrophic antiphospholipid syndrome: causes of death and prognostic
factors in a series of 250 patients. Arthritis Rheum. 2006 Aug;54(8):2568-76.
PubMed PMID: 16868979.

40: Reber G, Tincani A, Sanmarco M, de Moerloose P, Boffa MC; European Forum on
Antiphospholipid Antibodies Standardization Group. Variability of anti-beta2
glycoprotein I antibodies measurement by commercial assays. Thromb Haemost. 2005
Sep;94(3):665-72. PubMed PMID: 16268487.

41: Tincani A, Allegri F, Balestrieri G, Reber G, Sanmarco M, Meroni P, Boffa MC.
Minimal requirements for antiphospholipid antibodies ELISAs proposed by the
European Forum on antiphospholipid antibodies. Thromb Res. 2004;114(5-6):553-8.
Review. PubMed PMID: 15507291.

42: Boffa MC, Aurousseau MH, Lachassinne E, Dauphin H, Fain O, Le Toumelin P,
Uzan M, Piette JC, Derenne S, Boinot C, Avcin T, Motta M, Faden D, Tincani A.
European register of babies born to mothers with antiphospholipid syndrome.
Lupus. 2004;13(9):713-7. PubMed PMID: 15485110.

43: Reber G, Tincani A, Sanmarco M, de Moerloose P, Boffa MC; Standardization
group of the European Forum on Antiphospholipid Antibodies. Proposals for the
measurement of anti-beta2-glycoprotein I antibodies. Standardization group of the
European Forum on Antiphospholipid Antibodies. J Thromb Haemost. 2004
Oct;2(10):1860-2. PubMed PMID: 15456509.

44: Reber G, Schousboe I, Tincani A, Sanmarco M, Kveder T, de Moerloose P, Boffa
MC, Arvieux J. Inter-laboratory variability of anti-beta2-glycoprotein I
measurement. A collaborative study in the frame of the European Forum on
Antiphospholipid Antibodies Standardization Group. Thromb Haemost. 2002
Jul;88(1):66-73. PubMed PMID: 12152681.

45: Tincani A, Allegri F, Sanmarco M, Cinquini M, Taglietti M, Balestrieri G,
Koike T, Ichikawa K, Meroni P, Boffa MC. Anticardiolipin antibody assay: a
methodological analysis for a better consensus in routine determinations--a
cooperative project of the European Antiphospholipid Forum. Thromb Haemost. 2001
Aug;86(2):575-83. PubMed PMID: 11522006.

46: Eschwège V, Darnige L, Piette JC, Boffa MC. European Forum on
Antiphospholipid Antibodies: report on the first meeting, 10-11 October 1997,
Hôpital Saint-Louis, Paris. Lupus. 1998;7(7):439-44. PubMed PMID: 9796845.

Home